AMBEAS Stock Overview
Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities primarily in Sweden, Norway, and Denmark.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Ambea AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr46.66 |
| 52 Week High | kr46.66 |
| 52 Week Low | kr33.52 |
| Beta | 1.2 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 14.19% |
| 3 Year Change | n/a |
| 5 Year Change | -43.10% |
| Change since IPO | -41.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| AMBEAS | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.7% | 1.1% |
| 1Y | 14.2% | -30.5% | 1.9% |
Return vs Industry: AMBEAS exceeded the UK Healthcare industry which returned -14.1% over the past year.
Return vs Market: AMBEAS exceeded the UK Market which returned -4.3% over the past year.
Price Volatility
| AMBEAS volatility | |
|---|---|
| AMBEAS Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: AMBEAS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AMBEAS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 31,000 | Mark Jensen | www.ambea.se |
Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities in Sweden, Norway, and Denmark. It operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The Nytida segment comprises social care services and schools for children and young people with neuropsychiatric disorders.
Ambea AB (publ) Fundamentals Summary
| AMBEAS fundamental statistics | |
|---|---|
| Market cap | kr4.50b |
| Earnings (TTM) | kr344.00m |
| Revenue (TTM) | kr13.13b |
13.1x
P/E Ratio0.3x
P/S RatioIs AMBEAS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBEAS income statement (TTM) | |
|---|---|
| Revenue | kr13.13b |
| Cost of Revenue | kr9.80b |
| Gross Profit | kr3.33b |
| Other Expenses | kr2.98b |
| Earnings | kr344.00m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 08, 2024
| Earnings per share (EPS) | 3.84 |
| Gross Margin | 25.33% |
| Net Profit Margin | 2.62% |
| Debt/Equity Ratio | 52.6% |
How did AMBEAS perform over the long term?
See historical performance and comparison